NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/08/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization79.73 mln
Float22.07 mln
Earnings Date05/15/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-0.12
Highly suspicious
Relative Strength
66
/ 100
Outperforming
Debt / Equity
1.49
Elevated leverage
ROE
17.51
Healthy
Dividend Yield
0.00%
No dividend
Business Description
Fortress Biotech is a Florida-based pharmaceutical company that develops and sells a wide range of medical treatments, with a particular focus on skin conditions such as acne, rosacea, and fungal infections. Beyond dermatology, the company is advancing treatments for serious illnesses including cancer, rare genetic disorders, and post-surgical pain. It also has a growing pipeline of early and pre-clinical therapies spanning areas such as gout, brain tumors, and gene therapy. Founded in 2006 and originally known as Coronado Biosciences, the company works across multiple stages of drug development, from early research through to commercial sales.